GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 113 filers reported holding GW PHARMACEUTICALS PLC in Q1 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $6,856,000 | +300.9% | 31,611 | +113.3% | 0.00% | – |
| Q4 2020 | $1,710,000 | -8.4% | 14,821 | -22.7% | 0.00% | – |
| Q3 2020 | $1,867,000 | -22.9% | 19,175 | -2.9% | 0.00% | – |
| Q2 2020 | $2,422,000 | +26.5% | 19,738 | -9.7% | 0.00% | – |
| Q1 2020 | $1,914,000 | +96.1% | 21,855 | +134.2% | 0.00% | – |
| Q4 2019 | $976,000 | -2.4% | 9,333 | +7.3% | 0.00% | – |
| Q3 2019 | $1,000,000 | -34.1% | 8,694 | -1.3% | 0.00% | – |
| Q2 2019 | $1,518,000 | +7.7% | 8,806 | +5.3% | 0.00% | – |
| Q1 2019 | $1,409,000 | +70.0% | 8,359 | -1.8% | 0.00% | – |
| Q4 2018 | $829,000 | +262.0% | 8,510 | +277.4% | 0.00% | – |
| Q3 2017 | $229,000 | +8.0% | 2,255 | +6.7% | 0.00% | – |
| Q2 2017 | $212,000 | -70.6% | 2,114 | -79.6% | 0.00% | – |
| Q4 2015 | $721,000 | – | 10,387 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |